These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 30502715)
1. FOXP3 and CD25 double staining antibody cocktails identify regulatory T cells in different types of tumor tissues using tissue microarrays. Liu X; Wang X; Ding J; Gao Y; Zhao Y; Zhao R; Sun Q; Zhang S Ann Diagn Pathol; 2019 Feb; 38():67-70. PubMed ID: 30502715 [TBL] [Abstract][Full Text] [Related]
2. CD4 Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296 [TBL] [Abstract][Full Text] [Related]
3. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients. Yip WK; Abdullah MA; Yusoff SM; Seow HF Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas. Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144 [TBL] [Abstract][Full Text] [Related]
5. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining. Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177 [TBL] [Abstract][Full Text] [Related]
6. Changes in CD4 Xue-Mei L; Jie C; Xuan D; Xiao-Xing L; Chun-Lin H; Yu-Jie L Exp Biol Med (Maywood); 2017 May; 242(9):918-925. PubMed ID: 28114815 [TBL] [Abstract][Full Text] [Related]
7. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer. Zhang L; Wang XI; Ding J; Sun Q; Zhang S Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176 [TBL] [Abstract][Full Text] [Related]
8. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. Al-Qahtani D; Anil S; Rajendran R J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381 [TBL] [Abstract][Full Text] [Related]
10. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells. Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667 [TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
12. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice. Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069 [TBL] [Abstract][Full Text] [Related]
13. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610 [TBL] [Abstract][Full Text] [Related]
14. Increased frequency and FOXP3 expression of human CD8 Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437 [TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects. Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018 [TBL] [Abstract][Full Text] [Related]